Reply to: Unlocking the potential of the geriatric nutritional risk indicator in predicting outcomes of neoadjuvant immunotherapy for esophageal cancer
Eur J Surg Oncol. 2024 May 9:108404.
doi: 10.1016/j.ejso.2024.108404.
Online ahead of print.
1 Department of Thoracic Oncological Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China; Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus) of Zhejiang Province, Zhejiang Cancer Hospital, Hangzhou, China.
2 Department of Thoracic Oncological Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China; Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus) of Zhejiang Province, Zhejiang Cancer Hospital, Hangzhou, China. Electronic address: Chenqix@yeah.net.